Combination immunomodulation for immune-checkpoint-inhibitor-associated myocarditis

por Johnson, Douglas B., Menzies, Alexander M.
Publicado 2023

Dabrafenib and its potential for the treatment of metastatic melanoma

por Menzies, Alexander M, Long, Georgina V, Murali, Rajmohan
Publicado 2012

Hypercalcaemia secondary to hypophysitis and cortisol deficiency: another immunotherapy-related adverse event

por Miller, Samuel R, Kumar, Shejil, Yuile, Alexander, Menzies, Alexander M
Publicado 2022

Immune Related Adverse Events of the Thyroid – A Narrative Review

por Muir, Christopher A., Tsang, Venessa H. M., Menzies, Alexander M., Clifton-Bligh, Roderick J.
Publicado 2022

Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment

por Livingstone, Ann, Howard, Kirsten, Menzies, Alexander M., Long, Georgina V., Stockler, Martin R., Morton, Rachael L.
Publicado 2023

Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors

por Muir, Christopher Alan, Menzies, Alexander M, Clifton-Bligh, Roderick John, Long, Georgina V, Scolyer, Richard A, Tsang, Venessa
Publicado 2021

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

por Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M., Long, Georgina V., Fernando, Suran L., Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot
Publicado 2020

Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews

por Livingstone, Ann, Dempsey, Kathy, Stockler, Martin R., Howard, Kirsten, Long, Georgina V., Carlino, Matteo S., Menzies, Alexander M., Morton, Rachael L.
Publicado 2021

Integration of Digital Pathologic and Transcriptomic Analyses Connects Tumor-Infiltrating Lymphocyte Spatial Density With Clinical Response to BRAF Inhibitors

por Ziemys, Arturas, Kim, Michelle, Menzies, Alexander M., Wilmott, James S., Long, Georgina V., Scolyer, Richard A., Kwong, Larry, Holder, Ashley, Boland, Genevieve
Publicado 2020

Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma

por Menzies, Alexander M., Haydu, Lauren E., Carlino, Matteo S., Azer, Mary W. F., Carr, Peter J. A., Kefford, Richard F., Long, Georgina V.
Publicado 2014

VEGF Inhibitors Improve Survival Outcomes in Patients with Liver Metastases across Cancer Types—A Meta-Analysis

por Conway, Jordan W., Braden, Jorja, Lo, Serigne N., Scolyer, Richard A., Carlino, Matteo S., Menzies, Alexander M., Long, Georgina V., da Silva, Ines Pires
Publicado 2023

Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside

por Wu, Linda, Tsang, Venessa H. M., Sasson, Sarah C., Menzies, Alexander M., Carlino, Matteo S., Brown, David A., Clifton-Bligh, Roderick, Gunton, Jenny E.
Publicado 2021

Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series

por Carlino, Matteo S, Vanella, Vito, Girgis, Christina, Giannarelli, Diana, Guminski, Alex, Festino, Lucia, Kefford, Richard F, Menzies, Alexander M, Long, Georgina V, Ascierto, Paolo A
Publicado 2016

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”

por Tsang, Venessa H M, McGrath, Rachel T, Clifton-Bligh, Roderick J, Scolyer, Richard A, Jakrot, Valerie, Guminski, Alexander D, Long, Georgina V, Menzies, Alexander M
Publicado 2020

Current management of patients with melanoma who are found to be sentinel node‐positive

por Nijhuis, Amanda A. G., Spillane, Andrew J., Stretch, Jonathan R., Saw, Robyn P. M., Menzies, Alexander M., Uren, Roger F., Thompson, John F., Nieweg, Omgo E.
Publicado 2019

Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies

por Gide, Tuba N., Paver, Elizabeth C., Yaseen, Zarwa, Maher, Nigel, Adegoke, Nurudeen, Menzies, Alexander M., Pires da Silva, Ines, Wilmott, James S., Long, Georgina V., Scolyer, Richard A.
Publicado 2023

Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma

por Dieng, Mbathio, Turner, Robin M., Lord, Sarah J., Einstein, Andrew J., Menzies, Alexander M., Saw, Robyn P. M., Nieweg, Omgo E., Thompson, John F., Morton, Rachael L.
Publicado 2022

Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol

por Dieng, Mbathio, Khanna, Nikita, Nguyen, Mai Thi Hoang, Turner, Robin, Lord, Sarah J, Menzies, Alexander M, Allen, Jay, Saw, Robyn, Nieweg, Omgo E, Thompson, John, Morton, Rachael L
Publicado 2020

Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA

por Diefenbach, Russell J., Lee, Jenny H., Stewart, Ashleigh, Menzies, Alexander M., Carlino, Matteo S., Saw, Robyn P. M., Stretch, Jonathan R., Long, Georgina V., Scolyer, Richard A., Rizos, Helen
Publicado 2022

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

por Nahar, Kazi J, Rawson, Robert V, Ahmed, Tasnia, Tattersall, Stephen, Sandanayake, Neomal, Kiely, Christopher J, Lo, Serigne, Carlino, Matteo, Palendira, Umaimainthan, Scolyer, Richard A, Long, Georgina V, Menzies, Alexander M
Publicado 2020